CD4 Count as a Determinant in Clinicalepidemiological Profile of HIV Positive Patients: A Cross-sectional Study

Anusha Rashmi, Rashmi Kundapur

Abstract


Introduction: With anti-retroviral drugs mortality from HIV has reduced over the past decade. There is a decline in deaths due to HIV/AIDS evident since mid- 2000’s. Progression of disease to different stages largely depends on the immune status of the individual. A depleting CD4 count correlates with progression of HIV. Hence, this study was carried out with the objective to find the various factors affecting the CD4 count.

Materials and Methods: Information was gathered from a total of 1000 patient’s on ART medication attending the ART centre at the district government hospital was collected for a period of one year. Descriptive statistics, one sample t test and ANOVA were used for analysis.

Results: 71.4% of the attendees the CD4 count was below 500 cells/mm3. The mean CD4 was significantly higher in: Females [Mean = 450.72 +/-213.63 (p = 0.001)]. It was also significantly different with respect to adherence, duration of disease, habits and opportunistic infections.

Conclusion: CD4 count was influenced by gender, age, duration of disease and treatment and by personal habits like smoking and alcohol. It alone can be taken as a predictor of disease progression.


Keywords


Clinical-epidemiological profile, CD4 count, HIV

Full Text:

PDF

References


UNAIDS World AIDS Day Report. 2012. Cited 2018 Jun

Available from: http://www.unaids.org.

UNAIDS Corporate publications. UNAIDS Report on

the Global AIDS Epidemic. 2012. Cited 2018 Jun 11.

Available from: http://www.unaids.org/en/resources/

publications/2012/.

Srinivasula S, Lempicki RA, Adelsberger JW et al.

Differential effects of HIV viral load and CD4 count

on proliferation of naive and memory CD4 and CD8 T

lymphocytes. Blood 2011; 118(2): 262-70.

Miller V, Phillips AN, Clotet B et al. Association of

virus load, CD4 cell count, and treatment with clinical

progression in human immunodeficiency virus–infected

patients with very low CD4 cell count. The Journal of

Infectious Diseases 2002; 186(2): 189-97.

Langford, Simone E, Ananworanich J et al. Predictors

of disease progression in HIV infection: a review. AIDS

Research and Therapy 2007; 4: 11.

Gezie, Lemma D. Predictors of CD4 count over time

among HIV patients initiated ART in Felege Hiwot

Referral Hospital, Northwest Ethiopia: multilevel

analysis. BMC Res Notes. 2016; 9: 377.

Montarroyos UR, Miranda-Filho DB, César CC et al.

Factors related to changes in CD4+ T-cell counts over

time in patients with HIV/AIDS: a multilevel analysis.

PLoS ONE 2014; 9(2): e84276.

Shah B, Walshe L, Saple DG et al. Adherence to

Antiretroviral Therapy and Virologic Suppression

among HIV-Infected Persons Receiving Care in Private

Clinics in Mumbai, India. Clin Infect Dis 2007; 44(9):

-44.

Kumar R, Jha P, Arora P et al. Trends in HIV-1 in young

adults in south India from 2000 to 2004: a prevalence

study. Lancet 2006; 367(9517): 1164-72.

Sharma R. Profile of attendee for voluntary counselling

and testing in the ICTC, Ahmedabad. Indian Journal of

Sexually Transmitted Diseases and AIDS 2009; 30(1): 31.

Jayarama S, Shenoy S, Unnikrishnan B et al. Profiles of

attendees in voluntary counselling and testing centres

of a Medical College Hospital in Coastal Karnataka.

Indian J Community Med 2008; 33(1): 43-6.

Sanjeev Badiger RT. A profile of patients attending an

Anti-Retroviral Therapy (ART) centre at a tertiary care

hospital in South India. Australasian Medical Journal

; 3(6): 344-8.

Kumarasamy N, Venkatesh KK, Devaleenol B et al.

Factors associated with mortality among HIV-infected

patients in the era of highly active antiretroviral therapy

in southern India. International Journal of Infectious

Diseases 2010; 14(2): e127-31.

Modi B, Patel P, Patel S. A profile of patients registered

at art centre At Surat Municipal Institute of Medical

Education & amp; Research in Surat City, Gujarat, India.

Journal of Tuberculosis, Lung Diseases and HIV/AIDS

; 8(2): 11-6.

Sandhu GK. Tuberculosis: current situation, challenges

and overview of its control programs in india. J Glob

Infect Dis 2011; 3(2): 143-50.

Egger S, Petoumenos K, Kamarulzaman A et al. Longterm

patterns in CD4 response is determined by an

interaction between baseline CD4 cell count, viral load

and time: the Asia Pacific HIV Observational Database

(APHOD). J Acquir Immune Defic Syndr 2009; 50(5):

-20.

Viard JP, Mocroft A, Chiesi A et al. Influence of age on

CD4 cell recovery in human immunodeficiency virus–

infected patients receiving highly active antiretroviral

therapy: evidence from the EuroSIDA Study. J Infect

Dis 2001; 183(8): 1290-4.

Collazos J, Asensi V, Cartón JA. Sex differences in the

clinical, immunological and virological parameters of

HIV-infected patients treated with HAART. AIDS 2007;

(7): 835-43.

Akinbami A, Dosunmu A, Adediran A et al. CD4 count

pattern and demographic distribution of treatmentnaive

HIV patients in Lagos, Nigeria. AIDS Research

and Treatment 2012: 352753.

Ghate M, Deshpande S, Tripathy S et al. Incidence

of common opportunistic infections in HIV-infected

individuals in Pune, India: analysis by stages ofimmunosuppression represented by CD4 counts. Int

J Infect Dis 2009; 13(1): e1-8.

Powers KA, Poole C, Pettifor AE et al. Rethinking the

heterosexual infectivity of HIV-1: a systematic review

and meta-analysis. Lancet Infect Dis 2008; 8(9): 553-63.

Hussain T, Sinha S, Kulshreshtha KK et al. Seroprevalence

of HIV infection among tuberculosis patients in Agra,

India - a hospital-based study. Tuberculosis 2006; 86(1):

-9.

Sharma R. Profile of HIV-positives and determinants

with mode of transmission of HIV/AIDS patients on

anti-retroviral treatment center at civil hospital,

Ahmedabad. Indian J Sex Transm Dis 2011; 32(1): 14-8.

Hogg RS, Yip B, Chan KJ et al. Rates of disease

progression by baseline CD4 cell count and viral load

after initiating triple-drug therapy. JAMA 2001; 286(20):

-77.

Morgan D, Mahe C, Mayanja B et al. HIV-1 infection

in rural Africa: is there a difference in median time to

AIDS and survival compared with that in industrialized

countries? AIDS 2002; 16(4): 597-603.

Nash D, Katyal M, Brinkhof MW et al. Long-term

immunologic response to antiretroviral therapy in

low-income countries: a collaborative analysis of

prospective studies. AIDS 2008; 22(17): 2291-302.

LeMoing V, Thiébaut R, Chêne G et al. Predictors

of long-term increase in CD4+ cell counts in human

immunodeficiency virus-infected patients receiving a

protease inhibitor-containing antiretroviral regimen.

J Infect Dis 2002; 185(4): 471-80.

Tarwater PM, Margolick JB, Jin J et al. Increase and

plateau of CD4 T-cell counts in the 3(1/2) years after

initiation of potent antiretroviral therapy. J Acquir

Immune Defic Syndr 2001; 27(2): 168-75.

Ledergerber B, Lundgren JD, Walker AS et al. Predictors

of trend in CD4-positive T-cell count and mortality

among HIV-1-infected individuals with virological failure

to all three antiretroviral-drug classes. Lancet 2004;

(9428): 51-62.

Nieman RB, Fleming J, Coker RJ et al. The effect of

cigarette smoking on the development of AIDS in HIV-

-seropositive individuals. AIDS 1993; 7(5): 705-10.

Shuter J, Bernstein SL. Cigarette smoking is an

independent predictor of nonadherence in HIV-infected

individuals receiving highly active antiretroviral therapy.

Nicotine Tob Res 2008; 10(4): 731-6.

Lucas GM, Gebo KA, Chaisson RE et al. Longitudinal

assessment of the effects of drug and alcohol abuse

on HIV-1 treatment outcomes in an urban clinic. AIDS

; 16(5): 767-74.


Refbacks

  • There are currently no refbacks.


Copyright (c) 2018 Epidemiology International (ISSN: 2455-7048)

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.